These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 21999227)
1. The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model. Sener E; Yuksel N; Yildiz DK; Yilmaz B; Ozdemir O; Caglar Y; Degirmenci E Curr Eye Res; 2011 Nov; 36(11):1005-13. PubMed ID: 21999227 [TBL] [Abstract][Full Text] [Related]
2. Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization. Ozdemir O; Altintas O; Altintas L; Yildiz DK; Sener E; Caglar Y Can J Ophthalmol; 2013 Apr; 48(2):115-20. PubMed ID: 23561605 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). Kim TI; Kim SW; Kim S; Kim T; Kim EK Cornea; 2008 Apr; 27(3):349-52. PubMed ID: 18362666 [TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of trastuzumab on corneal neovascularization. Güler M; Yilmaz T; Ozercan I; Elkiran T Am J Ophthalmol; 2009 Apr; 147(4):703-708.e2. PubMed ID: 19054498 [TBL] [Abstract][Full Text] [Related]
5. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model. Öner V; Küçükerdönmez C; Akova YA; Çolak A; Karalezli A Ophthalmic Res; 2012; 48(3):118-23. PubMed ID: 22538642 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits. Kim EK; Kong SJ; Chung SK Cornea; 2014 Jan; 33(1):60-4. PubMed ID: 24240485 [TBL] [Abstract][Full Text] [Related]
7. Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits. Yoo AR; Chung SK Cornea; 2014 Oct; 33(10):1088-94. PubMed ID: 25119962 [TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats. Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599 [TBL] [Abstract][Full Text] [Related]
9. Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs. Hurmeric V; Mumcuoglu T; Erdurman C; Kurt B; Dagli O; Durukan AH Cornea; 2008 Apr; 27(3):357-62. PubMed ID: 18362668 [TBL] [Abstract][Full Text] [Related]
10. Topical and subconjunctival ranibizumab (lucentis) for corneal neovascularization in experimental rat model. Türkcü FM; Cinar Y; Türkcü G; Sahin A; Cingü AK; Yüksel H; Sahin M; Yıldırım A; Caça I Cutan Ocul Toxicol; 2014 Jun; 33(2):138-44. PubMed ID: 23859535 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model. Papathanassiou M; Theodossiadis PG; Liarakos VS; Rouvas A; Giamarellos-Bourboulis EJ; Vergados IA Am J Ophthalmol; 2008 Mar; 145(3):424-431. PubMed ID: 18207123 [TBL] [Abstract][Full Text] [Related]
12. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization. Ozdemir O; Altintas O; Altintas L; Ozkan B; Akdag C; Yüksel N Arq Bras Oftalmol; 2014 Aug; 77(4):209-13. PubMed ID: 25410169 [TBL] [Abstract][Full Text] [Related]
14. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model. Liarakos VS; Papaconstantinou D; Vergados I; Douvali M; Theodossiadis PG Eur J Ophthalmol; 2014; 24(3):299-308. PubMed ID: 24242219 [TBL] [Abstract][Full Text] [Related]
15. Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model. Avisar I; Weinberger D; Kremer I Curr Eye Res; 2010 Feb; 35(2):108-15. PubMed ID: 20136420 [TBL] [Abstract][Full Text] [Related]
16. Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization. Kaya MK; Demir T; Bulut H; Akpolat N; Turgut B Clin Exp Ophthalmol; 2015 Jul; 43(5):449-57. PubMed ID: 25640924 [TBL] [Abstract][Full Text] [Related]
17. The effect of subconjunctival suramin on corneal neovascularization in rabbits. Lee HS; Chung SK Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290 [TBL] [Abstract][Full Text] [Related]
18. Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats. Hashemian MN; Z-Mehrjardi H; Moghimi S; Tahvildari M; Mojazi-Amiri H Ophthalmic Res; 2011; 46(1):50-4. PubMed ID: 21212709 [TBL] [Abstract][Full Text] [Related]
19. The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization. Eski MT; Teberik K; Oltulu P; Ankaralı H; Kaya M; Alpay M Hum Exp Toxicol; 2022; 41():9603271221084674. PubMed ID: 35465742 [TBL] [Abstract][Full Text] [Related]
20. Effect of bevacizumab on corneal neovascularization in experimental rabbit model. Ahmed A; Berati H; Nalan A; Aylin S Clin Exp Ophthalmol; 2009 Sep; 37(7):730-6. PubMed ID: 19788671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]